| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1025066254 |
| P356 | DOI | 10.1007/S10803-012-1540-X |
| P932 | PMC publication ID | 3484245 |
| P698 | PubMed publication ID | 22562209 |
| P5875 | ResearchGate publication ID | 224914737 |
| P50 | author | Irva Hertz-Picciotto | Q6074204 |
| Ana-maria Iosif | Q42891101 | ||
| Sally Ozonoff | Q51025201 | ||
| P2093 | author name string | Cheryl Walker | |
| Robin L Hansen | |||
| Ousseny Zerbo | |||
| P2860 | cites work | Maternal infection and immune involvement in autism | Q22252357 |
| Maternal Infection Requiring Hospitalization During Pregnancy and Autism Spectrum Disorders | Q22252629 | ||
| The CHARGE study: an epidemiologic investigation of genetic and environmental factors contributing to autism | Q24553624 | ||
| Maternal immune activation alters fetal brain development through interleukin-6. | Q24653759 | ||
| Is fever suppression involved in the etiology of autism and neurodevelopmental disorders? | Q24799948 | ||
| Autistic disorder and viral infections | Q28243027 | ||
| Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring | Q28259611 | ||
| Severe 2009 H1N1 Influenza in Pregnant and Postpartum Women in California | Q29305524 | ||
| The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism | Q29547456 | ||
| Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. | Q33963518 | ||
| Circulating cytokines as mediators of fever | Q34102600 | ||
| Prenatal and perinatal risk factors for autism in China | Q34280525 | ||
| Serologic evidence of prenatal influenza in the etiology of schizophrenia | Q34338056 | ||
| Stereotypies and hyperactivity in rhesus monkeys exposed to IgG from mothers of children with autism | Q34588189 | ||
| Increased midgestational IFN-γ, IL-4 and IL-5 in women bearing a child with autism: A case-control study | Q35207114 | ||
| Cytokines and fever | Q35672751 | ||
| Maternal hyperthermia and the risk for neural tube defects in offspring: systematic review and meta-analysis | Q36036249 | ||
| Review: Hyperthermia and fever during pregnancy | Q36577751 | ||
| Neonatally measured immunoglobulins and risk of autism | Q38412982 | ||
| Viral exposure and autism | Q40235173 | ||
| Elevated maternal and fetal serum interleukin-6 levels are associated with epidural fever. | Q40572618 | ||
| Intrapartum fever and unexplained seizures in term infants | Q40612671 | ||
| Maternal Infection and Cerebral Palsy in Infants of Normal Birth Weight | Q40648005 | ||
| Autism in children with congenital rubella | Q43582958 | ||
| No association between prenatal exposure to influenza and autism | Q44489194 | ||
| Amniotic fluid inflammatory cytokines: potential markers of immunologic dysfunction in autism spectrum disorders | Q44616626 | ||
| Transfer of inflammatory cytokines across the placenta | Q44780433 | ||
| Amniotic fluid chemokines and autism spectrum disorders: an exploratory study utilizing a Danish Historic Birth Cohort | Q45121530 | ||
| Prenatal infection and risk for schizophrenia: IL-1beta, IL-6, and TNFalpha inhibit cortical neuron dendrite development | Q47761919 | ||
| Possible association between congenital cytomegalovirus infection and autistic disorder | Q48205787 | ||
| Prenatal and postnatal maternal contributions in the infection model of schizophrenia | Q48609673 | ||
| The role of cytokines in mediating effects of prenatal infection on the fetus: implications for schizophrenia | Q48764514 | ||
| Perinatal risk factors and infantile autism | Q50302838 | ||
| Autism diagnostic interview: a standardized investigator-based instrument | Q50307054 | ||
| Cytokine levels during pregnancy influence immunological profiles and neurobehavioral patterns of the offspring. | Q50312672 | ||
| Perinatal complications as predictors of infantile autism | Q50346042 | ||
| Epidemiologic associations with cerebral palsy | Q84807800 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | autism | Q38404 |
| P304 | page(s) | 25-33 | |
| P577 | publication date | 2013-01-01 | |
| P1433 | published in | Journal of Autism and Developmental Disorders | Q6294817 |
| P1476 | title | Is maternal influenza or fever during pregnancy associated with autism or developmental delays? Results from the CHARGE (CHildhood Autism Risks from Genetics and Environment) study | |
| P478 | volume | 43 |
| Q90358580 | A Comparison of Prenatal Exposures in Children with and without a Diagnosis of Autism Spectrum Disorder |
| Q93348892 | A Prospective Study of Environmental Exposures and Early Biomarkers in Autism Spectrum Disorder: Design, Protocols, and Preliminary Data from the MARBLES Study |
| Q50301146 | A Review of Oxytocin and Arginine-Vasopressin Receptors and Their Modulation of Autism Spectrum Disorder. |
| Q46326120 | Advances in nonhuman primate models of autism: Integrating neuroscience and behavior |
| Q38702052 | Annual Research Review: The role of the environment in the developmental psychopathology of autism spectrum condition |
| Q28487975 | Antipurinergic therapy corrects the autism-like features in the poly(IC) mouse model |
| Q58089631 | Association of Autism Spectrum Disorder With Prenatal Exposure to Medication Affecting Neurotransmitter Systems |
| Q35701367 | Associations between residence at birth and mental health disorders: a spatial analysis of retrospective cohort data |
| Q37499930 | Autism prevalence in the United States with respect to solar UV-B doses: An ecological study |
| Q39353531 | Autism spectrum disorder: neuropathology and animal models |
| Q33794904 | Autism spectrum disorders and race, ethnicity, and nativity: a population-based study |
| Q37654171 | Brighter children? The association between seasonality of birth and child IQ in a population-based birth cohort |
| Q61811133 | Characterizing the Interplay Between Autism Spectrum Disorder and Comorbid Medical Conditions: An Integrative Review |
| Q91614876 | De novo Blood Biomarkers in Autism: Autoantibodies against Neuronal and Glial Proteins |
| Q33551727 | Deficits in bioenergetics and impaired immune response in granulocytes from children with autism |
| Q91329903 | Dynamics of cortical progenitors and production of subcerebral neurons are altered in embryos of a maternal inflammation model for autism |
| Q50302007 | Early exposure to the combined measles-mumps-rubella vaccine and thimerosal-containing vaccines and risk of autism spectrum disorder |
| Q89539201 | Effect of Baby Walker Use on Developmental Status based on Ages and Stages Questionnaire Score (ASQ) |
| Q58767367 | Emerging Developments in Microbiome and Microglia Research: Implications for Neurodevelopmental Disorders |
| Q34679392 | Emerging Roles for the Gut Microbiome in Autism Spectrum Disorder |
| Q33824115 | Environmental factors associated with autism spectrum disorder: a scoping review for the years 2003-2013. |
| Q33823078 | Epidemiological and Serological Investigation into the Role of Gestational Maternal Influenza Virus Infection and Autism Spectrum Disorders |
| Q35054571 | Epigenetics of autism-related impairment: copy number variation and maternal infection |
| Q37638802 | Epigenomic strategies at the interface of genetic and environmental risk factors for autism |
| Q33882648 | Examining the Causes of Autism |
| Q37474300 | Fetal origins of autism spectrum disorders: the non-associated maternal factors |
| Q40134529 | Fever during pregnancy linked to child motor development |
| Q28072346 | Fever: Views in Anthroposophic Medicine and Their Scientific Validity |
| Q21131232 | Gene-environment interactions in human health: case studies and strategies for developing new paradigms and research methodologies |
| Q26741618 | Genetic Syndromes, Maternal Diseases and Antenatal Factors Associated with Autism Spectrum Disorders (ASD) |
| Q34659061 | Genetic epidemiology and insights into interactive genetic and environmental effects in autism spectrum disorders |
| Q35149520 | Heat shock alters the expression of schizophrenia and autism candidate genes in an induced pluripotent stem cell model of the human telencephalon |
| Q59335713 | Immune Dysfunction and Autoimmunity as Pathological Mechanisms in Autism Spectrum Disorders |
| Q22252563 | Immune Dysregulation in Autism Spectrum Disorder |
| Q28540753 | Impairment of translation in neurons as a putative causative factor for autism |
| Q57493929 | Inflammation: A Proposed Intermediary Between Maternal Stress and Offspring Neuropsychiatric Risk |
| Q54982081 | Interplay Between Peripheral and Central Inflammation in Autism Spectrum Disorders: Possible Nutritional and Therapeutic Strategies. |
| Q36833588 | Is autism a disease of the cerebellum? An integration of clinical and pre-clinical research. |
| Q50304452 | Levels of metals in the blood and specific porphyrins in the urine in children with autism spectrum disorders |
| Q40962449 | Low-dose suramin in autism spectrum disorder: a small, phase I/II, randomized clinical trial |
| Q54254373 | Maternal Exposures Associated with Autism Spectrum Disorder in Jamaican Children. |
| Q57446190 | Maternal Immune Activation Alters Adult Behavior, Gut Microbiome and Juvenile Brain Oscillations in Ferrets |
| Q30238718 | Maternal Immune Activation and Autism Spectrum Disorder: From Rodents to Nonhuman and Human Primates |
| Q33940810 | Maternal Infection During Pregnancy and Autism Spectrum Disorders |
| Q64125855 | Maternal diabetes and hypertensive disorders in association with autism spectrum disorder |
| Q91565067 | Maternal fever during pregnancy and offspring attention deficit hyperactivity disorder |
| Q38259759 | Maternal immune activation and abnormal brain development across CNS disorders. |
| Q35064112 | Maternal immune activation leads to activated inflammatory macrophages in offspring |
| Q91314954 | Maternal immune activation: reporting guidelines to improve the rigor, reproducibility, and transparency of the model |
| Q34395256 | Maternal intake of supplemental iron and risk of autism spectrum disorder |
| Q22242882 | Maternal lifestyle and environmental risk factors for autism spectrum disorders |
| Q36915376 | Maternal mid-pregnancy C-reactive protein and risk of autism spectrum disorders: the early markers for autism study |
| Q89832023 | Maternal stressors and the developmental origins of neuropsychiatric risk |
| Q40126120 | Maternal use of acetaminophen during pregnancy and risk of autism spectrum disorders in childhood: A Danish national birth cohort study |
| Q61798466 | Melanotan-II reverses autistic features in a maternal immune activation mouse model of autism |
| Q31020010 | Merging data from genetic and epigenetic approaches to better understand autistic spectrum disorder |
| Q35691087 | MicroRNA Profiling of Neurons Generated Using Induced Pluripotent Stem Cells Derived from Patients with Schizophrenia and Schizoaffective Disorder, and 22q11.2 Del. |
| Q46186302 | Microglia from offspring of dams with allergic asthma exhibit epigenomic alterations in genes dysregulated in autism |
| Q39368500 | Month of Conception and Learning Disabilities: A Record-Linkage Study of 801,592 Children |
| Q33840900 | Neonatal cytokines and chemokines and risk of Autism Spectrum Disorder: the Early Markers for Autism (EMA) study: a case-control study |
| Q27928004 | Neuroinflammation in Autism: Plausible Role of Maternal Inflammation, Dietary Omega 3, and Microbiota |
| Q28396205 | Neuronal connectivity as a convergent target of gene × environment interactions that confer risk for Autism Spectrum Disorders |
| Q90175268 | Placental DNA methylation levels at CYP2E1 and IRS2 are associated with child outcome in a prospective autism study |
| Q36036127 | Population attributable fractions for three perinatal risk factors for autism spectrum disorders, 2002 and 2008 autism and developmental disabilities monitoring network |
| Q35559923 | Preeclampsia, placental insufficiency, and autism spectrum disorder or developmental delay |
| Q41159016 | Pregnancy risk factors in autism: a pilot study with artificial neural networks |
| Q98177760 | Pregnancy, Viral Infection, and COVID-19 |
| Q57491425 | Prenatal Immune and Endocrine Modulators of Offspring's Brain Development and Cognitive Functions Later in Life |
| Q41217642 | Prenatal Infection and Autism Spectrum Disorders in Childhood: A Population-Based Case-Control Study in Taiwan |
| Q60500705 | Prenatal Stress, Maternal Immune Dysregulation, and Their Association With Autism Spectrum Disorders |
| Q36909689 | Prenatal and Newborn Immunoglobulin Levels from Mother-Child Pairs and Risk of Autism Spectrum Disorders |
| Q38643982 | Prenatal exposure to fever is associated with autism spectrum disorder in the boston birth cohort |
| Q38728728 | Prenatal fever and autism risk |
| Q50003376 | Prenatal paracetamol exposure and child neurodevelopment: A review |
| Q58549228 | Preterm Birth and the Risk of Neurodevelopmental Disorders - Is There a Role for Epigenetic Dysregulation? |
| Q98772458 | Prospects for improving future mental health of children through prenatal maternal micronutrient supplementation in China |
| Q64103670 | Rational use of mesenchymal stem cells in the treatment of autism spectrum disorders |
| Q30582584 | Reversal of autism-like behaviors and metabolism in adult mice with single-dose antipurinergic therapy. |
| Q64244994 | Risk and Protective Environmental Factors Associated with Autism Spectrum Disorder: Evidence-Based Principles and Recommendations |
| Q33788661 | Risk factors in autism: Thinking outside the brain |
| Q36738328 | Role of p53, Mitochondrial DNA Deletions, and Paternal Age in Autism: A Case-Control Study |
| Q40137458 | SOMANZ guidelines for the investigation and management sepsis in pregnancy |
| Q64244349 | Sex and gender bias in the experimental neurosciences: the case of the maternal immune activation model |
| Q91890631 | Sex-Dependent Effects of Perinatal Inflammation on the Brain: Implication for Neuro-Psychiatric Disorders |
| Q47661943 | Social impairments in autism spectrum disorder are related to maternal immune history profile. |
| Q35233868 | Spatial relative risk patterns of autism spectrum disorders in Utah |
| Q40160383 | Studying the effects of maternal febrile exposures on neurological outcomes in offspring: conceptual and methodological issues. |
| Q38930020 | The Role of the Immune System in Autism Spectrum Disorder |
| Q41678457 | The maternal body as environment in autism science |
| Q35878852 | The microbiome and childhood diseases: Focus on brain-gut axis |
| Q28391614 | The serotonin system in autism spectrum disorder: From biomarker to animal models |
| Q28709645 | Toxoplasmosis and Polygenic Disease Susceptibility Genes: Extensive Toxoplasma gondii Host/Pathogen Interactome Enrichment in Nine Psychiatric or Neurological Disorders |
| Q36128146 | Transient Shifts of Incubation Temperature Reveal Immediate and Long-Term Transcriptional Response in Chicken Breast Muscle Underpinning Resilience and Phenotypic Plasticity |
| Q92690842 | Use of Negative Control Exposure Analysis to Evaluate Confounding: An Example of Acetaminophen Exposure and Attention-Deficit/Hyperactivity Disorder in Nurses' Health Study II |
| Q52629015 | Vaccination Patterns in Children After Autism Spectrum Disorder Diagnosis and in Their Younger Siblings. |
| Q35533016 | ZNF804A Transcriptional Networks in Differentiating Neurons Derived from Induced Pluripotent Stem Cells of Human Origin |
Search more.